DoW Announces Line-by-Line Review of Certain 8(a) Contracts Amid Government-wide Scrutiny of the 8(a) Program
NYDFS Issues Guidance on Third-Party Cybersecurity Risk Management: What Regulated Entities Need to Know
FTC Signals Continued Enforcement of “Made in USA” Labeling Rule and Guidance
Healthcare Fraud Enforcement in a Second Trump Administration: Trends, Priorities, and Implications
FDA to Expand Unannounced Inspections of Foreign Facilities — Manufacturers, Research Firms Should Prepare
Practical Tips for Companies Following President Trump’s Pause on FCPA Enforcement